HCW Biologics Inc.

NASDAQ (USD): HCW Biologics Inc. (HCWB)

Last Price

0.713

Today's Change

+0.435 (156.47%)

Day's Change

0.557 - 1.03

Trading Volume

288,467,613

Overview

Market Cap

26 Million

Shares Outstanding

37 Million

Avg Volume

9,935,253

Avg Price (50 Days)

0.45

Avg Price (200 Days)

0.68

PE Ratio

-0.70

EPS

-1.01

Earnings Announcement

01-Apr-2025

Previous Close

0.28

Open

0.97

Day's Range

0.5567 - 1.03

Year Range

0.21 - 2.52

Trading Volume

289,004,709

Price Change Highlight

1 Day Change

152.59%

5 Day Change

123.08%

1 Month Change

60.07%

3 Month Change

63.42%

6 Month Change

16.17%

Ytd Change

55.33%

1 Year Change

-39.42%

3 Year Change

-66.70%

5 Year Change

-88.85%

10 Year Change

-88.85%

Max Change

-88.85%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment